2016 — FHI 360 acts as an independent third party to assess the quality of Sino-implant (II). A quality assurance evaluation and monitoring program was implemented by FHI 360 to verify that Sino-implant (II) meets lot release specifications for the product. These annual reports expand on the results from the quality assurance evaluation and monitoring that began in 2008.